Untethered regimen

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone

Retrieved on: 
Wednesday, May 19, 2021
Clinical medicine, Medicine, Endocrinology, Diabetes, Insulin pump, Peptide hormones, Recombinant proteins, Insulin, Bolus, Intensive insulin therapy, Untethered regimen

The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus.

Key Points: 
  • The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus.
  • "Controlling an insulin pump and viewing its status via smartphone allows people with diabetes to use a device which is usually close at hand.
  • Using the mySugr Pump Control provides people with diabetes more discretion and simplicity with their everyday insulin pump therapy.
  • Users of the mySugr Pump Control are also able to get support from the mySugr Bolus Calculator, which calculates the needed amount of insulin for meal and correction boluses.

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone

Retrieved on: 
Wednesday, May 19, 2021
Clinical medicine, Medicine, Endocrinology, Diabetes, Insulin pump, Peptide hormones, Recombinant proteins, Insulin, Bolus, Intensive insulin therapy, Untethered regimen

The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus.

Key Points: 
  • The mySugr Pump Control is designed to enable people with diabetes to control an insulin pump directly via a smartphone: import its data, view its status, and remotely deliver a standard bolus.
  • "Controlling an insulin pump and viewing its status via smartphone allows people with diabetes to use a device which is usually close at hand.
  • Using the mySugr Pump Control provides people with diabetes more discretion and simplicity with their everyday insulin pump therapy.
  • Users of the mySugr Pump Control are also able to get support from the mySugr Bolus Calculator, which calculates the needed amount of insulin for meal and correction boluses.

Tandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ Technology

Retrieved on: 
Thursday, August 27, 2020
Diabetes, Health, Medical devices, Clinical medicine, Medicine, Endocrine system, RTT, Insulin pump, Insulin, Diabetes, Hypoglycemia, Tandem Diabetes Care, Untethered regimen, the t:slim X2 Insulin Pump, Tandem Diabetes Care, Inc.

Results demonstrated increased time spent in range (70-180 mg/dL) in children ages 6 to 13 years old using the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology.

Key Points: 
  • Results demonstrated increased time spent in range (70-180 mg/dL) in children ages 6 to 13 years old using the t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology.
  • The control group used either a sensor augmented pump without automated insulin dosing or Tandems t:slim X2 pump with Basal-IQ predictive low glucose suspend technology.
  • No severe hypoglycemia or diabetic ketoacidosis was reported, and 100 percent of participants using Control-IQ technology completed the study.
  • The t:slim X2 pump with Control-IQ technology also recently launched in select geographies outside the United States.